You are here

Sanofi

Sanofi scores with its subcutaneous version of Sarclisa as it tries to play catch up with J&J's Darzalex

Fierce Pharma

Thu, 01/9/25 - 11:55 am

Multiple Myeloma

LB Pharma's twist on old Sanofi drug passes schizophrenia test, teeing up phase 3 push

Fierce Biotech

Wed, 01/8/25 - 11:19 am

clinical trials

5 FDA decisions to watch in the first quarter of 2025

BioPharma Dive

Mon, 01/6/25 - 06:54 pm

Vertex Pharmaceuticals

non-opioid pain treatments

transthyretin amyloid cardiomyopathy

diazoxide choline

Prader Willi syndrome

I-Mab pauses Sanofi-partnered prospect to make play for busy CLDN18.2 space

Fierce Biotech

Mon, 01/6/25 - 10:57 am

Drugmakers plan price hikes for 250+ medications in 2025

Beckers Hospital Review

Wed, 01/1/25 - 10:31 pm

Bristol Myers Squibb

Sanofi scoops up China rights to Cytokinetics’ heart disease med ahead of approval decision

Fierce Biotech

Fri, 12/20/24 - 11:26 am

Corxel Pharmaceuticals

FDA grants fast-track status to combination mRNA flu and COVID-19 vaccine candidates

Beckers Hospital Review

Tue, 12/17/24 - 12:09 pm

Sanofi, Teva say study results show gut disease drug could be ‘best in class’

BioPharma Dive

Tue, 12/17/24 - 11:59 am

Teva Pharmaceutical

FDA Grants Breakthrough Therapy Designation to Sanofi’s Tolebrutinib for Non-Relapsing Secondary Progressive Multiple Sclerosis

Pharm Exec

Mon, 12/16/24 - 11:35 am

non-relapsing secondary progressive MS

Sanofi announces its biggest China investment deal amid China-EU trade tensions

MSN/Reuters

Mon, 12/2/24 - 10:51 am

drug manufacturing

Sanofi adds new $600M manufacturing plant

Beckers Hospital Review

Sun, 12/1/24 - 11:50 am

drug manufacturing

Sanofi plans to change hospital drug-discount program

Yahoo/Reuters

Sun, 11/24/24 - 06:01 pm

Sanofi lays out €40M to beef up transplant, diabetes drug production in France

Fierce Pharma

Mon, 11/18/24 - 06:37 pm

type 1 diabetes

drug manufacturing

FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease

Benzinga

Fri, 11/15/24 - 11:15 am

chronic spontaneous urticaria

Sanofi wins appeal in spat with NICE over Sarclisa

Pharmaphorum

Wed, 11/13/24 - 10:53 am

relapsed or refractory multiple myeloma

Formation Bio collaborates with Sanofi and OpenAI to Introduce Muse, a first of its kind AI tool to accelerate patient recruitment in drug development

PR Newswire

Tue, 11/12/24 - 09:55 am

artificial intelligent

clinical trials

clinical trial recruitment

Sanofi Beats Q3 Forecasts Fueled by 381% Growth in Beyfortus Sales

BioSpace

Fri, 10/25/24 - 11:22 am

Sanofi-backed Agomab raises $89m to advance fibrotic disease treatments

Pharmaceutical Technology

Fri, 10/25/24 - 11:08 am

fibrotic disease

Dengue is spreading and Sanofi is pulling the market’s only vaccine. What’s next?

Pharma Voice

Wed, 10/23/24 - 11:30 am

Sanofi moves ahead with CD&R deal for stake in consumer business

BioPharma Dive

Mon, 10/21/24 - 11:40 pm

consumer health

Pages